Share on StockTwits

Cytosorbents Corp (NASDAQ:CTSO) Director Al Kraus sold 50,000 shares of the stock on the open market in a transaction that occurred on Monday, August 4th. The stock was sold at an average price of $0.24, for a total value of $12,000.00. Following the transaction, the director now directly owns 1,393,631 shares of the company’s stock, valued at approximately $334,471. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Separately, analysts at Zacks reiterated an “outperform” rating on shares of Cytosorbents Corp in a research note on Friday, May 16th. They now have a $0.50 price target on the stock.

Shares of Cytosorbents Corp (NASDAQ:CTSO) traded down 2.04% during mid-day trading on Wednesday, hitting $0.24. The stock had a trading volume of 76,642 shares. Cytosorbents Corp has a one year low of $0.08 and a one year high of $0.35. The stock has a 50-day moving average of $0.24 and a 200-day moving average of $0.24. The company’s market cap is $71.8 million.

CytoSorbents Corporation is a development stage critical care focused company using blood purification to treat life-threatening illnesses.

Receive News & Ratings for Cytosorbents Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cytosorbents Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.